TRPM1 - transient receptor potential cation channel subfamily M member 1 Gene
Species: Macaca fascicularis
Gene Type: protein coding
Gene ID: 102145822
TRPM1 Products (11)
| mRNA | Protein | Name |
|---|---|---|
| XM_045395214.1 | XP_045251149.1 | transient receptor potential cation channel subfamily M member 1 isoform X10 |
| XM_045395213.1 | XP_045251148.1 | transient receptor potential cation channel subfamily M member 1 isoform X9 |
| XM_045395208.1 | XP_045251143.1 | transient receptor potential cation channel subfamily M member 1 isoform X5 |
| XM_045395206.1 | XP_045251141.1 | transient receptor potential cation channel subfamily M member 1 isoform X3 |
| XM_045395207.1 | XP_045251142.1 | transient receptor potential cation channel subfamily M member 1 isoform X4 |
| XM_045395205.1 | XP_045251140.1 | transient receptor potential cation channel subfamily M member 1 isoform X2 |
| XM_045395203.1 | XP_045251138.1 | transient receptor potential cation channel subfamily M member 1 isoform X1 |
| XM_045395211.1 | XP_045251146.1 | transient receptor potential cation channel subfamily M member 1 isoform X7 |
| XM_045395209.1 | XP_045251144.1 | transient receptor potential cation channel subfamily M member 1 isoform X6 |
| XM_045395210.1 | XP_045251145.1 | transient receptor potential cation channel subfamily M member 1 isoform X7 |
| XM_045395212.1 | XP_045251147.1 | transient receptor potential cation channel subfamily M member 1 isoform X8 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
transient receptor potential cation channel subfamily M member 1 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0151 | Pregnenolone | 99.85% | Unkown | |
| HY-110189 | Pregnenolone monosulfate sodium | 99.96% | Unkown | |
| HY-B1739 | Pregnenolone monosulfate | 99.96% | Unkown |
Clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-B0151R | Pregnenolone (Standard) | 99.91% | Phase 4 |
Pre-clinical Phase
Bioactive Molecules
(12)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-110220 | CIM0216 | Agonist | 99.94% | Unkown |
| HY-101464 | ML329 | Inhibitor | 98.0% | Unkown |
| HY-156483 | TT-012 | Inhibitor | 99.76% | Unkown |
| HY-B0151S2 | Pregnenolone-d4-1 | 99.34% | Unkown | |
| HY-110189S1 | Pregnenolone monosulfate-d4 sodium | 99.8% | Unkown | |
| HY-B0151S | Pregnenolone-d4 | / | Unkown | |
| HY-B0151S1 | Pregnenolone-13C2,d2 | 99.2% | Unkown | |
| HY-110189S | Pregnenolone monosulfate sodium-13C2,d2 | / | Unkown | |
| HY-B0151S3 | Pregnenolone-d6 | / | Unkown | |
| HY-RS15111 | TRPM1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS17998 | Trpm1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24470 | Trpm1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service